VAERS reports by lot

GSK Varicella/Shingles lot D3L5G: VAERS reports

20 VAERS reports list lot D3L5G as a GSK Varicella/Shingles vaccine, received between 2018-05-19 and 2020-12-02. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
20
Reports
15%
Marked serious
0
With a death outcome
7
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)2329%
Neurological1621%
Dermatological (non-injection-site)912%
Injection-site / Local reaction810%
Gastrointestinal56%
Cardiac / Cardiovascular45%
Psychiatric / Neuropsychiatric45%
Respiratory34%
Musculoskeletal34%
Thrombotic / Hematological23%
Allergic / Anaphylactic11%

Where reports came from

U.S. state of the reporter, where given (top 12).

California2
Florida2
Texas2
Indiana2
Connecticut2
Virginia1
New York1
North Carolina1
Arizona1
Washington1
Nevada1
Minnesota1

Reports by month received

2018-053
2018-067
2018-074
2018-092
2018-101
2018-112
2020-121

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.